Order Article Reprints

Saresella M, Zoia CP, La Rosa F, Bazzini C, Sala G, Grassenis E, Marventano I, Hernis A, Piancone F, Conti E, et al. Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. Pharmaceuticals. 2023; 16(12):1725. https://doi.org/10.3390/ph16121725

Saresella, Marina, Chiara Paola Zoia, Francesca La Rosa, Chiara Bazzini, Gessica Sala, Erica Grassenis, Ivana Marventano, Ambra Hernis, Federica Piancone, Elisa Conti, and et al. 2023. "Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation" Pharmaceuticals 16, no. 12: 1725. https://doi.org/10.3390/ph16121725

Saresella, M., Zoia, C. P., La Rosa, F., Bazzini, C., Sala, G., Grassenis, E., Marventano, I., Hernis, A., Piancone, F., Conti, E., Sesana, S., Re, F., Seneci, P., Ferrarese, C., & Clerici, M. (2023). Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. Pharmaceuticals, 16(12), 1725. https://doi.org/10.3390/ph16121725